Last week, Pfizer and BioNTech published preliminary data showing
the vaccine offered 90% protection against Covid-19 and there were no safety concerns.
Last week, Pfizer and BioNTech published preliminary data showing
the vaccine offered 90% protection against Covid-19 and there were no safety concerns.